Developing large-scale bioreactor protocols to expand pancreatic endocrine tissue to treat type 1 diabetes
dc.contributor.advisor | Behie, Leo A. | |
dc.contributor.author | Chawla, Meera | |
dc.date.accessioned | 2005-08-16T16:53:01Z | |
dc.date.available | 2005-08-16T16:53:01Z | |
dc.date.issued | 2004 | |
dc.description | Bibliography: p. 254-279 | en |
dc.description | Some pages are in colour. | en |
dc.description.abstract | Type 1 diabetes is a disease of the pancreas in which the beta islet (endocrine) cells, which are responsible for insulin production, are destroyed by the immune system. The expansion in bioreactors and subsequent transplantation of endocrine cells could revolutionize the treatment for Type 1 diabetes using the "world-famous" Edmonton Protocol. Consequently, the aim of this study was to develop a scaleable process to expand mammalian pancreatic endocrine tissue in suspension bioreactors. Issues regarding cell culture medium conditions and cell handling protocols were investigated. Experiments in suspension bioreactors for 9 days showed a greater than 7-fold increase in the number of insulin-positive cells. Furthermore, aggregates were islet-like, as all of the endocrine cell types were present. Most importantly, cells exhibited glucose-responsive behavior and thus functionality.. These results represent a major milestone on the path to effective expansion and clinical use of bioreactor-produced islet-like structures in the treatment of Type 1 diabetes. | en |
dc.format.extent | xxiii, 279 leaves : ill. ; 30 cm. | en |
dc.identifier.citation | Chawla, M. (2004). Developing large-scale bioreactor protocols to expand pancreatic endocrine tissue to treat type 1 diabetes (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/23736 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/23736 | |
dc.identifier.uri | http://hdl.handle.net/1880/41400 | |
dc.language.iso | eng | |
dc.publisher.institution | University of Calgary | en |
dc.publisher.place | Calgary | en |
dc.rights | University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | |
dc.title | Developing large-scale bioreactor protocols to expand pancreatic endocrine tissue to treat type 1 diabetes | |
dc.type | master thesis | |
thesis.degree.discipline | Chemical and Petroleum Engineering | |
thesis.degree.grantor | University of Calgary | |
thesis.degree.name | Master of Science (MSc) | |
ucalgary.item.requestcopy | true | |
ucalgary.thesis.accession | Theses Collection 58.002:Box 1494 520492011 | |
ucalgary.thesis.notes | UARC | en |
ucalgary.thesis.uarcrelease | y | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2004_Chawla.pdf
- Size:
- 39.4 MB
- Format:
- Adobe Portable Document Format
- Description: